David M. Knott Jr’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

David M. Knott Jr’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-566,487	Closed	-$2.38M	–	152
2023 Q1	$2.38M	Sell	566,487 -200	-0%	-$1.04K	0.93%	21
2022 Q4	$3.41M	Hold	566,687	–	–	1.29%	19
2022 Q3	$3.3M	Hold	566,687	–	–	1.39%	14
2022 Q2	$3.38M	Buy	566,687 +10,000	+2%	+$51.2K	1.42%	17
2022 Q1	$2.6M	Buy	556,687 +335,608	+152%	+$1M	0.83%	36
2021 Q4	$548K	Buy	+221,079	New	+$541K	0.19%	67

Other funds holding CTIC

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

David M. Knott Jr's CTIC Position: Q2 2023 in Review

David M. Knott Jr sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 566,487 shares — an estimated $2.38M sold.

David M. Knott Jr first reported a position in CTIC in Q4 2021 and held it in 6 quarters. The position peaked at $3.41M in Q4 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

David M. Knott Jr reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
David M. Knott Jr sold 566,487 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $2.38M.
David M. Knott Jr first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2021 and held it in 6 quarters.
David M. Knott Jr's CTI BioPharma Corp. (DE) Common Stock position peaked at $3.41M in Q4 2022.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on David M. Knott Jr's 13F filing for Q2 2023, filed 11 Aug 2023.